Evidence Based Pharmacological Treatments for Major Depressive Disorder

Prakash Masand, M.D., Consulting Professor of Psychiatry & Behavioral Sciences, Department of Psychiatry, Duke University Medical Center, Durham, NC

This presentation will discuss the latest evidence based pharmacological treatments for MDD including augmentation and combination strategies, STAR-D results and device based treatments. It will also discuss experimental treatments including ketamine.

Dr. Masand has disclosed that he is a Consultant for Dey Pharma, Eli Lilly and Company, Forest, Merck, Pfizer and Sunovion. Dr. Masand is a Stock Owner of Orexigen Therapeutics & Titan Pharmaceuticals. He will discuss off-label and investigational uses of pharmaceutical products during this presentation.

Location:	PBS Building, TU#3, 2nd Flr
Sponsor:	Department of Psychiatry and Behavioral Sciences
Contact:	Linette Thorp thorpl@upstate.edu 464-3104
copy this event into your personal desktop calendar